Anti-SARS-Cov-2 S-RBD IgG formed after BNT162b2 vaccination can bind C1q and activate complement
A. H. A. Abu-Humaidan, F. M. Ahmad, D. Awajan, R. Jarrar, N. Alaridah
This study compares C1q binding and complement activation by anti-SARS-CoV-2 RBD IgG from BNT162b2 and BBIBP-CorV vaccinated individuals, finding stronger C1q binding and complement activation with BNT162b2.
bioRxiv · Apr 24, 2022Immunology